European Commission to speed up access to drugs

March 2012
PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p11
The article reports on a proposal from the European Commission to reduce the time taken of national decisions on pricing and reimbursement for drugs to enter the market.


Related Articles

  • EC minsters take hard look at prices of drugs. Taylor, Robert // BMJ: British Medical Journal (International Edition);6/5/93, Vol. 306 Issue 6891, p1501 

    Focuses on the investigation of the European Commission on the prices of drugs in Europe. Impact of high prices of medicine on pensioners; Reason for refusal of drug companies to sell to some countries; Role of British government in reducing the tobacco consumption; Proposal to raise excise...

  • No More Dual Pricing. Gopal, Kevin // Pharmaceutical Executive;Jul2001, Vol. 21 Issue 7, p26 

    Reports on the European Commission's ban on GlaxoSmithKline's (GSK) dual pricing policy in Spain. Reason for the ban; Purpose of the dual pricing policy; Reaction of GSK to the ban.

  • Price controls seen as key to Europe's drug innovation lag. Mitchell, Peter // Nature Reviews Drug Discovery;Apr2007, Vol. 6 Issue 4, p257 

    The article discusses two reports showing that price controls were responsible for fewer new drugs being developed in Europe compared with the U.S. According to a report of the European Commission's Pharmaceutical Forum, the US has established itself in pharmaceutical innovations since the year...

  • European Pharma Industry Wins Major Legal Victory.  // Chemical Market Reporter;1/12/2004, Vol. 265 Issue 2, p6 

    Reports on the major legal victory won by the European pharmaceutical industry in its fight to curb the activities of traders exploiting differences in government-controlled medicine prices in the European Union. Basis of the Luxembourg-based European Court of Juctice's decision; Impact of the...

  • News in brief.  // Nature Reviews Drug Discovery;Jan2009, Vol. 8 Issue 1, p8 

    The article offers news briefs related to pharmaceutical industry. The 2009 Pharmaceutical Price Regulation Scheme Agreement in Great Britain is expected to encourage the development cost-effective medicines. The U.S. Federal Trade Commission held a roundtable meeting on November 21, 2008 which...

  • News and Analysis of the Global Innovation Scene. Blau, John; Gobble, MaryAnne M. // Research Technology Management;Jul/Aug2012, Vol. 55 Issue 4, p3 

    The article focuses on Europe's pharmaceutical industry and the effect the euro zone debt crisis is having on research and development. It states that European governments have been cutting prices and pushing for increased use of inexpensive generic drugs. It talks about measures the European...

  • Cracking Tokyo.  // Director (00123242);Jul97, Vol. 50 Issue 12, p33 

    Reports that the European Commission is offering grants worth 80,000 pounds to first-time United Kingdom participants in its Executive Training Programme (ETP) to go to Japan. Who programme is aimed at; Description of programme; Advantages of programme.

  • EC net initiative has U.S. worried. Rodger, Will // Inter@ctive Week;11/03/97, Vol. 4 Issue 38, p48 

    Reports on a threat made by privacy officials in the European Community to stop Europeans from sending electronic information of all kinds to the United States. Circumstances surrounding this action taken; Comments from Peter Swire, professor of law at Ohio State University and author of a...

  • Galileo ICD, Free at Last.  // GPS World;May2010, Vol. 21 Issue 5, p14 

    The article reports on the publication of the updated Galileo Open Service Signal-In-Space Interface Control Document (OS SIS ICD) by the European Commission (EC) in Europe.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics